These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4338589)

  • 1. 3-Cyclic amine derivatives of rifamycin: strong inhibitors of the DNA polymerase activity of RNA tumor viruses.
    Green M; Bragdon J; Rankin A
    Proc Natl Acad Sci U S A; 1972 May; 69(5):1294-8. PubMed ID: 4338589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA tumor viruses, DNA polymerases, and oncogenesis: some selective effects of rifampicin derivatives.
    Gallo RC; Smith RG; Whang-Peng J; Ting RC; Yang SS; Abrell JW
    Medicine (Baltimore); 1972 May; 51(3):159-68. PubMed ID: 4336642
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the products of DNA-directed DNA polymerases in oncogenic RNA viruses.
    Spiegelman S; Burny A; Das MR; Keydar J; Schlom J; Travnicek M; Watson K
    Nature; 1970 Aug; 227(5258):563-7. PubMed ID: 4317039
    [No Abstract]   [Full Text] [Related]  

  • 4. Rifamycin derivatives strongly inhibiting RNA leads to DNA polymerase (reverse transcriptase) of murine sarcoma viruses.
    Gurgo C; Ray R; Green M
    J Natl Cancer Inst; 1972 Jul; 49(1):61-79. PubMed ID: 4114001
    [No Abstract]   [Full Text] [Related]  

  • 5. Reverse transciptase from Mason-Pfizer monkey tumor virus, avian myeloblastosis virus, and Rauscher leukemia virus and its response to rifamycin derivatives.
    Gallo RC; Abrell JW; Robert MS; Yang SS; Smith RG
    J Natl Cancer Inst; 1972 Apr; 48(4):1185-9. PubMed ID: 4336883
    [No Abstract]   [Full Text] [Related]  

  • 6. Reverse transcriptase, RNA tumour virus transformation and derivatives of rifamycin SV.
    Ting RC; Yang SS; Gallo RC
    Nat New Biol; 1972 Apr; 236(67):163-6. PubMed ID: 4113337
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses.
    Gurgo C; Ray RK; Thiry L; Green M
    Nat New Biol; 1971 Jan; 229(4):111-4. PubMed ID: 4326810
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral antibiotics: inhibition of focus-formation in human or mouse cell cultures by sarcoma-inducing oncornaviruses with rifamycins.
    O'Connor TE; Schiop-Stansly P; Sethi VS; Hadidi A; Okano P
    Intervirology; 1974; 3(1-2):63-83. PubMed ID: 4373409
    [No Abstract]   [Full Text] [Related]  

  • 9. RNA-dependent DNA polymerase activity in five RNA viruses: divalent cation requirements.
    Scolnick E; Rands E; Aaronson SA; Todaro GJ
    Proc Natl Acad Sci U S A; 1970 Dec; 67(4):1789-96. PubMed ID: 4322157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of purified DNA polymerase of RNA tumor viruses by fluoranthene derivatives and analogues of tilorone hydrochloride.
    Green M; Rankin A; Gerard GF; Grandgenett DP; Green MR
    J Natl Cancer Inst; 1975 Aug; 55(2):433-42. PubMed ID: 51087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor of the DNA-dependent DNA polymerase of some RNA tumour viruses in feline sera.
    Roy-Burman P; Pal BK; Gardner MB
    Nat New Biol; 1972 May; 237(71):45-7. PubMed ID: 4338042
    [No Abstract]   [Full Text] [Related]  

  • 12. Defective mouse sarcoma virus deficient in DNA polymerase activity.
    May JT; Somers KD; Kit S
    J Gen Virol; 1972 Aug; 16(2):223-6. PubMed ID: 4342041
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of purified ribonucleic acid directed deoxyribonucleic acid polymerase of avian myeloblastosis virus and murine sarcoma-leukemia virus with a rifamycin SV derivative.
    Gurgo C; Grandgenett DP; Gerad GF; Green M
    Biochemistry; 1974 Feb; 13(4):708-13. PubMed ID: 4129863
    [No Abstract]   [Full Text] [Related]  

  • 14. Endonucleolytic DNase in oncorna viruses: role of mycoplasma.
    Huppert J; Delain E; Fossar N; May E
    Virology; 1974 Jan; 57(1):217-26. PubMed ID: 4362023
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA-directed DNA polymerase activity in oncogenic RNA viruses.
    Spiegelman S; Burny A; Das MR; Keydar J; Schlom J; Travnicek M; Watson K
    Nature; 1970 Sep; 227(5262):1029-31. PubMed ID: 4317810
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic DNA-RNA hybrids and RNA-RNA duplexes as templates for the polymerases of the oncogenic RNA viruses.
    Spiegelman S; Burny A; Das MR; Keydar J; Schlom J; Trávnícek M; Watson K
    Nature; 1970 Oct; 228(5270):430-2. PubMed ID: 4320564
    [No Abstract]   [Full Text] [Related]  

  • 17. Viral and cellular DNA polymerase: comparison of activities with synthetic and natural RNA templates.
    Robert MS; Smith RG; Gallo RC; Sarin PS; Abrell JW
    Science; 1972 May; 176(4036):798-800. PubMed ID: 4113240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rifamycin derivatives: specific inhibitors of nucleic acid polymerases.
    Gerard GF; Gurgo C; Grandgenett DP; Green M
    Biochem Biophys Res Commun; 1973 Jul; 53(1):194-201. PubMed ID: 4126333
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of three nucleotide polymerases by rifamycin derivatives.
    Thompson FM; Tischler AN; Adams J; Calvin M
    Proc Natl Acad Sci U S A; 1974 Jan; 71(1):107-9. PubMed ID: 4129799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of carcinogenesis by RNA tumour viruses: the RNA-and DNA-dependent DNA polymerase activities of feline sarcoma virus.
    Fujinaga K; Green M
    J Gen Virol; 1971 Aug; 12(2):85-93. PubMed ID: 5166273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.